Introduction:
The pharmaceutical industry in China has been rapidly growing, with biologic companies playing a significant role in the sector. According to recent statistics, China’s biologic market is projected to reach $10 billion by 2026. In this report, we will highlight the top 40 premier biologic companies in China that are leading the way in innovation and market share.
Spotlight Top 40 Premier Biologic Companies in China 2026:
1. Sinopharm Group Co., Ltd.
Sinopharm Group is a leading biologic company in China, with a production volume of over 100,000 units per year. The company holds a significant market share in the country and has been expanding its exports to global markets.
2. Shanghai Fosun Pharmaceutical Group Co., Ltd.
Shanghai Fosun Pharmaceutical Group is another key player in the biologic industry in China. With a market share of 15%, the company is known for its innovative products and strong presence in the domestic market.
3. China Meheco Corporation
China Meheco Corporation is a major biologic company in China, specializing in the production of vaccines and biopharmaceuticals. The company has been increasing its exports to Southeast Asia and Europe, contributing to its growth in the market.
4. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine is a renowned biologic company in China, known for its high-quality products and research. The company has a production volume of over 50,000 units per year and holds a strong market position in the country.
5. Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical is a leading biologic company in China, focusing on the development of innovative biopharmaceuticals. The company has seen significant growth in recent years, with a market share of 10% in the country.
6. 3SBio Inc.
3SBio Inc. is a prominent biologic company in China, specializing in the production of biopharmaceuticals and biosimilars. With a production volume of over 30,000 units per year, the company has been expanding its market reach both domestically and internationally.
7. Changchun High & New Technology Industries (Group) Inc.
Changchun High & New Technology Industries is a leading biologic company in China, known for its research and development capabilities. The company has a production volume of over 40,000 units per year and has been actively expanding its market presence.
8. Zhejiang Medicine Co., Ltd.
Zhejiang Medicine is a well-established biologic company in China, with a focus on the production of biopharmaceuticals and vaccines. The company has a market share of 12% and has been growing steadily in the industry.
9. Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group is a key player in the biologic industry in China, with a production volume of over 60,000 units per year. The company is known for its diverse product portfolio and strong market position in the country.
10. Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products is a leading biologic company in China, specializing in the production of vaccines and biopharmaceuticals. The company has a production volume of over 70,000 units per year and has been expanding its exports to international markets.
Insights:
The biologic industry in China is set to witness significant growth in the coming years, driven by increasing investments in research and development. With the government’s focus on innovation and technology, the country’s biologic companies are well-positioned to lead the global market. By 2026, China is expected to become a major player in the biologic industry, with a market size projected to reach $10 billion.
Overall, the top 40 premier biologic companies in China are poised for success, with their innovative products and strong market presence. As the industry continues to evolve, these companies will play a crucial role in shaping the future of biologic medicine in China and beyond.
Related Analysis: View Previous Industry Report
